[Form 4] Okta, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Mary Agnes Wilderotter, a director of Okta, Inc. (OKTA), was awarded 5,826 Restricted Stock Units (RSUs) in a transaction dated 08/13/2025. Each RSU converts into one share of Class A Common Stock. Following the grant, the Reporting Person beneficially owns 5,826 shares on a direct basis. The RSUs vest over three years: 33-1/3% on August 13, 2026 with the remainder vesting in two equal annual installments thereafter, subject to continued service. The Form 4 was signed by an attorney-in-fact, Larissa Schwartz, on 08/15/2025.
Positive
- Grant of 5,826 RSUs to a director aligns executive compensation with shareholder value
- Direct beneficial ownership of 5,826 shares is clearly disclosed
- Standard multi-year vesting schedule (33-1/3% after one year, then two equal annual installments) promotes retention
Negative
- None.
Insights
TL;DR: Routine director equity award aligning compensation with shareholder interests; standard multi-year vesting.
The Form 4 documents a non-derivative grant of 5,826 RSUs to a board director, which is a common mechanism to align long-term incentives. The vesting schedule—one-third after one year then two equal annual installments—matches typical service-based director award practices. The award is recorded as direct ownership and carries conversion one-for-one into Class A common stock. No cash exercise price is involved. The filing appears procedural and routine with no disclosures of additional arrangements or accelerated vesting.
TL;DR: Insider disclosure shows a standard equity grant; transaction poses no immediate liquidity event or sale.
The reported transaction is an acquisition code A for RSUs totaling 5,826 units, with $0 price reported for the underlying shares, indicating this is a compensation grant rather than a purchase. The Form 4 lists the transaction date as 08/13/2025 and indicates continued ownership of 5,826 direct shares post-transaction. The signature by an attorney-in-fact is properly noted. From an insider-trading compliance perspective, there is no indication in this filing of a contemporaneous sale or disposition.